Early chemotherapy response evaluation in tumors by 99mTc-DTPA- DG

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 3, 2008, Pages 363-370

  Liang, Jie ^a   Chen, Yue ^a   Huang, Zhanwen ^a   Zhao, Yanling ^a   He, Ling ^b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

99mTc DTPA DG; Drug therapy; Radionuclide imaging; Tumors

Indexed keywords

CISPLATIN; DIETHYLENETRIAMINEPENTAACETIC ACID DEOXYGLUCOSE TC 99M; DOXORUBICIN; PACLITAXEL; RADIOISOTOPE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER MODEL; CELL STRAIN MCF 7; CELL TYPE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TUMOR LEVEL; EVALUATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCINTIGRAPHY; TREATMENT RESPONSE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; FLOW CYTOMETRY; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; NEOPLASMS; TECHNETIUM TC 99M PENTETATE; TIME FACTORS;

EID: 46449127952     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0446     Document Type: Article

References (20)

1. Shin KH, Moon SH, Suh JS, et al. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res 2000;376:200.
2. Bar-Shalom R, Valdivia AY, Blaufox MD, et al. PET imaging in oncology. Radiology 2002;30:150.
3. Szyszko T, Al-Nahhas A, Canelo R, et al. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography. Nucl Med Commun 2007;28:15.
4. Ceresoli GL, Chiti A, Zucali PA, et al. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. J Clin Oncol 2006;24:4587.
5. Querellou S, Valette F, Bodet-Milin C, et al. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Ann Hematol 2006;85:759.
6. Tatsumi M, Cohade C, Mourtzikos KA, et al. Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 2006;33:254.
7. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007;34:463.
8. Yang DJ, Azhdarinia A, Kim EE. Tumor specific imaging using Tc-99m and Ga-68 labelled radiopharmaceuticals. Current Medical Imaging Reviews 2005;1:25.
9. 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology 2003;226:465.
10. 99mTc-ethylenedicysteine-glucosamine. Cancer Biother Radiopharm 2004;19:443.
11. 99mTc-DTPA-deoxyglucose: an experimental study. Cancer Biother Radiopharm 2007;22:403.
12. 99mTc]-DTPADG) as a potential imaging modality for tumors. Appl Radiat Isot 2006;64:342.
13. Gianni L, Capri G, Munzone E, et al. Paclitaxel (Taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines. Semin Oncol 1994;21:29.
14. López-Vivanco G, Viteri A, Barceló R, et al. Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer. Am J Clin Oncol 2005;28:501.
15. Montalar J, Morales S, Maestu I, et al. Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer. Lung Cancer 2001;34:305.
16. Nomura Y. Adriamycin-breast cancer. Gan To Kagaku Ryoho 1996;23:1911.
17. Icli F, Akbulut H, Dincol D, et al. A randomized trial of four cycles of adjuvant AC (adriamycin +- cyclophosphamide) +-/- two cycles of EP (etoposide -+ cisplatin) in node positive patients with breast cancer. Ann Oncol 2001;12:1011.
18. Smith TA. Facilitative glucose transporter expression in human cancer tissue. Br J Biomed Sci 1999;56:285.
19. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005;202:654.
20. Chung JK, Lee YJ, Kim SK, et al. Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer. Nucl Med Commun 2004;25:11.